KCNN4 and atrial fibrillation: As SK4 K+ channels are not only expressed in cardiomyocytes but also in fibroblasts and macrophages (23, 28–30, 32, 33), which all possess the inflammatory signaling machinery (17), we hypothesized that their pharmacological inhibition can reduce AF substrate by preventing atrial structural remodeling.